Please note this is a comparison between Version 2 by Nitin Chandra Teja Dadi and Version 1 by Nitin Chandra Teja Dadi.
Healthcare-associated infections (HAIs) are caused by nosocomial pathogens. HAIs have an immense impact not only on developing countries but also on highly developed parts of world. They are predominantly device-associated infections that are caused by the planktonic form of microorganisms as well as those organized in biofilms. This review elucidates the impact of HAIs, focusing on device-associated infections such as central line-associated bloodstream infection including catheter infection, catheter-associated urinary tract infection, ventilator-associated pneumonia, and surgical site infections.The most relevant microorganisms are mentioned in terms ofassociated with their frequency of infection on medical devices. Standard care bundles, conventional therapy, and novel approaches against device-associated infections are briefly mentioned as well. This review concisely summarizes relevant and up-to-date information on HAIs and HAI-associated microorganisms and also provides a description of several useful approaches for tackling HAIpeculiar microorganisms along with conventional and novel therapies
Monegro, A.F.; Muppidi, V.; Regunath, H. Hospital Acquired Infections; StatPearls Publishing: Treasure Island, FL, USA; Las Vegas, NV, USA, 2021.
European Centre for Disease Prevention and Control. Surveillance of Healthcare-Associated Infections and Prevention Indicators in European Intensive Care Units Year: Hai-Net Icu Protocol; Version 2.2; ECDC: Stockholm, Sweden, 2017; Available online: https://www.ecdc.europa.eu/en/publications-data/surveillance-healthcare-associated-infections-and-prevention-indicators-european (accessed on 23 September 2021).
Walter, J.; Haller, S.; Quinten, C.; Kärki, T.; Zacher, B.; Eckmanns, T.; Abu Sin, M.; Plachouras, D.; Kinross, P.; Suetens, C. Healthcare-Associated Pneumonia in Acute Care Hospitals in European Union/European Economic Area Countries: An Analysis of Data from a Point Prevalence Survey, 2011 to 2012. Eurosurveillance 2012, 32, 1700843.
Suetens, C.; Latour, K.; Kärki, T.; Ricchizzi, E.; Kinross, P.; Moro, M.L.; Jans, B.; Hopkins, S.; Hansen, S.; Lyytikäinen, O.; et al. Prevalence of Healthcare-Associated Infections, Estimated Incidence and Composite Antimicrobial Resistance Index in Acute Care Hospitals and Long-Term Care Facilities: Results from Two European Point Prevalence Surveys, 2016 to 2017. Eurosurveillance 2018, 23, 1800516.
World Health Organization. Prevention of Hospital-Acquired Infections: A Practical Guide, 2nd ed.; World Health Organization: Geneva, Switzerland, 2002; Available online: https://www.who.int/csr/resources/publications/drugresist/WHO_CDS_CSR_EPH_2002_12/en/ (accessed on 30 March 2020).
Badia, J.M.; Casey, A.L.; Petrosillo, N.; Hudson, P.M.; Mitchell, S.A.; Crosby, C. Impact of Surgical Site Infection on Healthcare Costs and Patient Outcomes: A Systematic Review in Six European Countries. J. Hosp. Infect. 2017, 96, 1–15.
Zingg, W.; Hopkins, S.; Gayet-Ageron, A.; Holmes, A.; Sharland, M.; Suetens, C.; Almeida, M.; Asembergiene, J.; Borg, M.A.; Budimir, A.; et al. Health-Care-Associated Infections in Neonates, Children, and Adolescents: An Analysis of Paediatric Data from the European Centre for Disease Prevention and Control Point-Prevalence Survey. Lancet Infect. Dis. 2017, 17, 381–389.
European Centre for Disease Prevention and Control. Economic Evaluations of Interventions to Prevent Healthcare-Associated Infections: Literature Review; Publications Office: Stockholm, Sweden, 2017.
Duszynska, W.; Rosenthal, V.D.; Szczesny, A.; Zajaczkowska, K.; Fulek, M.; Tomaszewski, J. Device Associated –Health Care Associated Infections Monitoring, Prevention and Cost Assessment at Intensive Care Unit of University Hospital in Poland (2015–2017). BMC Infect. Dis. 2020, 20, 761.
Hopmans, T.E.M.; Smid, E.A.; Wille, J.C.; Kooi, T.I.I.; van der Koek, M.B.G.; Vos, M.C.; Geerlings, S.E.; Greeff, S.C. De Trends in Prevalence of Healthcare-Associated Infections and Antimicrobial Use in Hospitals in the Netherlands: 10 Years of National Point-Prevalence Surveys.2020. J. Hosp. Infect. 2020, 104, 181–187.
Vandecandelaere, I.; Matthijs, N.; van Nieuwerburgh, F.; Deforce, D.; Vosters, P.; de Bus, L.; Nelis, H.J.; Depuydt, P.; Coenye, T. Assessment of Microbial Diversity in Biofilms Recovered from Endotracheal Tubes Using Culture Dependent and Independent Approaches. PLoS ONE 2012, 7, e38401.
Holá, V.; Ruzicka, F.; Horka, M. Microbial Diversity in Biofilm Infections of the Urinary Tract with the Use of Sonication Techniques. FEMS Immunol. Med. Microbiol. 2010, 59, 525–528.
Boev, C.; Kiss, E. Hospital-Acquired Infections: Current Trends and Prevention. Crit. Care Nurs. Clin. N. Am. 2017, 29, 51–65.
Gentili, A.; Di Pumpo, M.; La Milia, D.I.; Vallone, D.; Vangi, G.; Corbo, M.I.; Berloco, F.; Cambieri, A.; Damiani, G.; Ricciardi, W.; et al. A Six-Year Point Prevalence Survey of Healthcare-Associated Infections in an Italian Teaching Acute Care Hospital. Int. J. Environ. Res. Public Health 2020, 17, 7724.
Böll, B.; Schalk, E.; Buchheidt, D.; Hasenkamp, J.; Kiehl, M.; Kiderlen, T.R.; Kochanek, M.; Koldehoff, M.; Kostrewa, P.; Claßen, A.Y.; et al. Central Venous Catheter-Related Infections in Hematology and Oncology: 2020 Updated Guidelines on Diagnosis, Management, and Prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann. Hematol. 2021, 100, 239–259.
Wendel, D.; Mezoff, E.A.; Raghu, V.K.; Kinberg, S.; Soden, J.; Avitzur, Y.; Rudolph, J.A.; Gniadek, M.; Cohran, V.C.; Venick, R.S.; et al. Management of Central Venous Access in Children With Intestinal Failure: A Position Paper From the NASPGHAN Intestinal Rehabilitation Special Interest Group. J. Pediatr. Gastroenterol. Nutr. 2021, 72, 474–486.
Menegueti, M.G.; Ciol, M.A.; Bellissimo-Rodrigues, F.; Auxiliadora-Martins, M.; Gaspar, G.G.; Canini, S.R.M.; da Silva Canini, S.R.M.; Basile-Filho, A.; Laus, A.M. Long-Term Prevention of Catheter-Associated Urinary Tract Infections among Critically Ill Patients through the Implementation of an Educational Program and a Daily Checklist for Maintenance of Indwelling Urinary Catheters: A Quasi-Experimental Study. Medicine 2019, 98, e14417.
Gad, M.H.; AbdelAziz, H.H. Catheter-Associated Urinary Tract Infections in the Adult Patient Group: A Qualitative Systematic Review on the Adopted Preventative and Interventional Protocols From the Literature. Cureus 2021, 13, e16284.
Letica-Kriegel, A.S.; Salmasian, H.; Vawdrey, D.K.; Youngerman, B.E.; Green, R.A.; Furuya, E.Y.; Calfee, D.P.; Perotte, R. Identifying the Risk Factors for Catheter-Associated Urinary Tract Infections: A Large Cross-Sectional Study of Six Hospitals. BMJ Open 2019, 9, e022137.
Vincitorio, D.; Barbadoro, P.; Pennacchietti, L.; Pellegrini, I.; David, S.; Ponzio, E.; Prospero, E. Risk Factors for Catheter-Associated Urinary Tract Infection in Italian Elderly. Am. J. Infect. Control 2014, 42, 898–901.
Medina-Polo, J.; Gil-Moradillo, J.; González-Díaz, A.; Abad-López, P.; Santos-Pérez de la Blanca, R.; Hernández-Arroyo, M.; Peña-Vallejo, H.; Téigell-Tobar, J.; Calzas-Montalvo, C.; Caro-González, P.; et al. Observational Study over 8-Year Period Evaluating Microbiological Characteristics and Risk Factor for Isolation of Multidrug-Resistant Organisms (MDRO) in Patients with Healthcare-Associated Infections (HAIs) Hospitalized in a Urology Ward. GMS Infect. Dis. 2021, 9, Doc04.
Li, Y.-C.; Lin, H.-L.; Liao, F.-C.; Wang, S.-S.; Chang, H.-C.; Hsu, H.-F.; Chen, S.-H.; Wan, G.-H. Potential Risk for Bacterial Contamination in Conventional Reused Ventilator Systems and Disposable Closed Ventilator-Suction Systems. PLoS ONE 2018, 13, e0194246.
de Souza Kock, K.; Maurici, R. Respiratory Mechanics, Ventilator-Associated Pneumonia and Outcomes in Intensive Care Unit. World J. Crit. Care Med. 2018, 7, 24–30.
Percival, S.L.; Suleman, L.; Vuotto, C.; Donelli, G. Healthcare-Associated Infections, Medical Devices and Biofilms: Risk, Tolerance and Control. J. Med. Microbiol. 2015, 64, 323–334.
Ling, M.L.; Apisarnthanarak, A.; Jaggi, N.; Harrington, G.; Morikane, K.; Thu, L.T.A.; Ching, P.; Villanueva, V.; Zong, Z.; Jeong, J.S.; et al. APSIC Guide for Prevention of Central Line Associated Bloodstream Infections (CLABSI). Antimicrob. Resist. Infect. Control 2016, 5, 16.
Pinto, H.; Simões, M.; Borges, A. Prevalence and Impact of Biofilms on Bloodstream and Urinary Tract Infections: A Systematic Review and Meta-Analysis. Antibiotics 2021, 10, 825.
Svensson Malchau, K.; Tillander, J.; Zaborowska, M.; Hoffman, M.; Lasa, I.; Thomsen, P.; Malchau, H.; Rolfson, O.; Trobos, M. Biofilm Properties in Relation to Treatment Outcome in Patients with First-Time Periprosthetic Hip or Knee Joint Infection. J. Orthop. Transl. 2021, 30, 31–40.